Keywords: novoseven, cleared, eu, new, uses, european, commission

NovoSeven cleared in EU for two new uses

Article | 01 March 2004

Print This

The European Commission has approved the use of Novo Nordisk's NovoSeven (eptacog alfa [activated]) for the control of bleeding in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in